In this special ESCMID episode, Dr Shradha Subedi and Dr Umang Agrawal introduce their latest studies on the impact of rapid syndromic testing; one conducted in Australia, the other in India. Together, they discuss how these diagnostics influence clinical decisions, the contrasts in patient management across regions, and the broader implications for the antimicrobial landscape.

Hosted on Acast. See acast.com/privacy for more information.